Overflow Tests on Grass-Covered Embankments at the Living Lab Hedwige-Prosperpolder: An Overview

In regions with a temperate climate, a well-maintained grass sod on a clay layer is considered a reliable protection for dams and dikes. In the Living Lab Hedwige-Prosperpolder, on the left bank of the Scheldt river straddling the border between Belgium and the Netherlands, a series of 27 overflow tests with a purpose-built overflow generator has been executed to determine the strength of the protective layer against erosion at various conditions. The goal of this paper is to inform on the executed test program and the initial results. From the results, it was concluded that in general, a high-quality grass cover on the landside dike slope can withstand high overflow discharges well for 12 to 30 h, without severe erosion damage. Anomalies, such as the presence of animal burrows, reed vegetation, and already present deformations can strongly reduce the resistance of the cover layer and may lead to failure within a couple of hours

The perspective of people with axial spondyloarthritis regarding physiotherapy : room for the implementation of a more active approach

Objectives. Physiotherapy is recommended in the management of people with axial spondyloarthritis (axSpA), with new insights into its preferred content and dosage evolving. The aim of this study was to describe the use and preferences regarding individual and group physiotherapy among people with axSpA. Methods. A cross-sectional survey was conducted among people with axSpA living in The Netherlands (NL) and Switzerland (CH). Results. Seven hundred and thirteen people with axSpA participated (56.7% male, median age 55 years, median Assessment of Spondyloarthritis International Society Health Index score 4.2). Response rates were 45% (n¼206) in NL and 29% in CH (n¼507). Of these participants, 83.3% were using or had been using physiotherapy. Individual therapy only was used or had been used by 36.7%, a combination of individual plus land- and water-based group therapy by 29.1% and group therapy by only 5.3%. Fewer than half of the participants attending individual therapy reported active therapy (such as aerobic, muscle strength and flexibility exercises). Although the majority (75.9%) were not aware of the increased cardiovascular risk, participants showed an interest in cardiovascular training, either individually or in a supervised setting. If supervised, a majority, in CH (75.0%) more than in NL (55.7%), preferred supervision by a specialized physiotherapist. Conclusion. The majority of people with axSpA use or have used physiotherapy, more often in an individual setting than in a group setting. The content of individual therapy should be more active; in both therapy settings, aerobic exercises should be promoted. In particular, enabling people with axSpA to perform exercises independently would meet their needs and might enhance their daily physical activity

Translation of automotive module RF immunity test limits into equivalent IC test limits using S-parameter IC models

A method to translate immunity specifications of automotive modules into equivalent requirements at integrated circuit (IC) level, using linear scattering parameter models of the ICs, is presented. A technique is described to determine S-parameters of ICs by simulations based on back-annotated analog schematics. The simulation results are compared with measurement data obtained using a specially designed test board. As an example, simulation and measurement results are given for the input stage of an automotive sensor interface. A good agreement is obtained from the lowest test frequency up to 1 GHz. Above this value, the measured results seem to be dominated by package effects

Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST)

<p><b>Background and Purpose:</b> The Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) unadjusted results demonstrated that intravenous alteplase is well tolerated and that the effects were comparable with those seen in randomized, controlled trials (RCTs) when used in routine clinical practice within 3 hours of ischemic stroke onset. We aimed to identify outcome predictors and adjust the outcomes of the SITS-MOST to the baseline characteristics of RCTs.</p> <p><b>Methods:</b> The study population was SITS-MOST (n=6483) and pooled RCTs (n=464) patients treated with intravenous alteplase within 3 hours of stroke onset. Multivariable, backward stepwise regression analyses (until P≤0.10) were performed to identify the outcome predictors for SITS-MOST. Variables appearing either in the final multivariable model or differing (P<0.10) between SITS-MOST and RCTs were included in the prediction model for the adjustment of outcomes. Main outcome measures were symptomatic intracerebral hemorrhage, defined as National Institutes of Health Stroke Scale deterioration ≥1 within 7 days with any hemorrhage (RCT definition), mortality, and independency as defined by modified Rankin Score of 0 to 2 at 3 months.</p> <p><b>Results:</b> The adjusted proportion of symptomatic intracerebral hemorrhage for SITS-MOST was 8.5% (95% CI, 7.9 to 9.0) versus 8.6% (6.3 to 11.6) for pooled RCTs; mortality was 15.5% (14.7 to 16.2) versus 17.3% (14.1 to 21.1); and independency was 50.4% (49.6 to 51.2) versus 50.1% (44.5 to 54.7), respectively. In the multivariable analysis, older age, high blood glucose, high National Institutes of Health Stroke Scale score, and current infarction on imaging scans were related to poor outcome in all parameters. Systolic blood pressure, atrial fibrillation, and weight were additional predictors of symptomatic intracerebral hemorrhage. Current smokers had a lower rate of symptomatic intracerebral hemorrhage. Disability before current stroke (modified Rankin Score 2 to 5), diastolic blood pressure, antiplatelet other than aspirin, congestive heart failure, patients treated in new centers, and male sex were related to high mortality at 3 months.</p> <p><b>Conclusions:</b> The adjusted outcomes from SITS-MOST were almost identical to those in relevant RCTs and reinforce the conclusion drawn previously in the unadjusted analysis. We identified several important outcome predictors to better identify patients suitable for thrombolysis.</p&gt

Lupine Allergy: Not Simply Cross-Reactivity with Peanut or Soy

Background: Reports of lupine allergy are increasing as its use in food products increases. Lupine allergy might be the consequence of cross-reactivity after sensitization to peanut or other legumes or de novo sensitization. Lupine allergens have not been completely characterized. Objectives: We sought to identify allergens associated with lupine allergy, evaluate potential cross-reactivity with peanut, and determine eliciting doses (EDs) for lupine allergy by using double-blind, placebo-controlled food challenges. Methods: Six patients with a history of allergic reactions to lupine flour were evaluated by using skin prick tests, CAP tests, and double-blind, placebo-controlled food challenges. Three of these patients were also allergic to peanut. Lupine allergens were characterized by means of IgE immunoblotting and peptide sequencing. Results: In all 6 patients the ED for lupine flour was 3 mg or less for subjective symptoms and 300 mg or more for objective symptoms. The low ED and moderate-to-severe historical symptoms indicate significant allergenicity of lupine flour. Two patients allergic to lupine but not to peanut displayed IgE binding predominantly to approximately 66-kd proteins and weak binding to 14- and 24-kd proteins, whereas patients with peanut allergy and lupine allergy showed weak binding to lupine proteins of about 14 to 21 or 66 kd. Inhibition of binding was primarily species specific. Conclusion: Lupine allergy can occur either separately or together with peanut allergy, as demonstrated by 3 patients who are cosensitized to peanut and lupine. Clinical implications: Lupine flour is allergenic and potentially cross-reactive with peanut allergen, thus posing some risk if used as a replacement for soy flour

Dense gas in IRAS 20343+4129: an ultracompact HII region caught in the act of creating a cavity

The intermediate- to high-mass star-forming region IRAS 20343+4129 is an excellent laboratory to study the influence of high- and intermediate-mass young stellar objects on nearby starless dense cores, and investigate for possible implications in the clustered star formation process. We present 3 mm observations of continuum and rotational transitions of several molecular species (C2H, c-C3H2, N2H+, NH2D) obtained with the Combined Array for Research in Millimetre-wave Astronomy, as well as 1.3 cm continuum and NH3 observations carried out with the Very Large Array, to reveal the properties of the dense gas. We confirm undoubtedly previous claims of an expanding cavity created by an ultracompact HII region associated with a young B2 zero-age main sequence (ZAMS) star. The dense gas surrounding the cavity is distributed in a filament that seems squeezed in between the cavity and a collimated outflow associated with an intermediate-mass protostar. We have identified 5 millimeter continuum condensations in the filament. All of them show column densities consistent with potentially being the birthplace of intermediate- to high-mass objects. These cores appear different from those observed in low-mass clustered environments in sereval observational aspects (kinematics, temperature, chemical gradients), indicating a strong influence of the most massive and evolved members of the protocluster. We suggest a possible scenario in which the B2 ZAMS star driving the cavity has compressed the surrounding gas, perturbed its properties and induced the star formation in its immediate surroundings.Comment: 17 pages, 13 figures. Accepted for publication in Monthly Notices of the Royal Astronomical Society (Main Journal

The molecular distribution of the IRDC G351.77-0.51

Infrared dark clouds are massive, dense clouds seen in extinction against the IR Galactic background. Many of these objects appear to be on the verge of star and star cluster formation. Our aim is to understand the physical properties of IRDCs in very early evolutionary phases. We selected the filamentary IRDC G351.77 - 0.51, which is remarkably IR quiet at 8{\mu}m. As a first step, we observed mm dust continuum emission and rotational lines of moderate and dense gas tracers to characterise different condensations along the IRDC and study the velocity field of the filament. Our initial study confirms coherent velocity distribution along the infrared dark cloud ruling out any coincidental projection effects. Excellent correlation between MIR extinction, mm continuum emission and gas distribution is found. Large-scale turbulence and line profiles throughout the filament is indicative of a shock in this cloud. Excellent correlation between line width, and MIR brightness indicates turbulence driven by local star formation.Comment: accepted for publication in A&

The rotterdam study: 2014 objectives and design update

The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands. The study targets cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, oncological, and respiratory diseases. As of 2008, 14,926 subjects aged 45 years or over comprise the Rotterdam Study cohort. The findings of the Rotterdam Study have been presented in over a 1,000 research articles and reports (see www.erasmus-epidemiology.nl/rotterdamstudy). This article gives the rationale of the study and its design. It also presents a summary of the major findings and an update of the objectives and methods